AVIR icon

Atea Pharmaceuticals

132 hedge funds and large institutions have $213M invested in Atea Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

2% more funds holding

Funds holding: 129132 (+3)

5% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 39

0.27% more ownership

Funds ownership: 68.13%68.39% (+0.27%)

Holders
132
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$341K
Puts
$247K
Net Calls
Net Calls Change

Top Buyers

1 +$8.36M
2 +$7.57M
3 +$3.03M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.38M
5
Two Sigma Investments
Two Sigma Investments
New York
+$655K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.14M
27
$1.14M
28
$1.09M
29
$935K
30
$807K
31
$787K
32
$761K
33
$733K
34
$677K
35
$662K
36
$655K
37
$593K
38
$591K
39
$528K
40
$466K
41
$462K
42
$460K
43
$383K
44
$380K
45
$376K
46
$370K
47
$363K
48
$345K
49
$334K
50
$330K